allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text History 5 Sponsors 1

No text version has been ingested for this bill yet.

PASSAGE PROBABILITY

3.8% Unlikely

Why this number

Stage base In Committee — base rate 27%, measured from NH's completed sessions
Momentum -4 30/100 from the pace of recorded action
Time since last action -22 2012 days quiet
Sponsor influence +4 85/100

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.